Phosphoramidites - RNA / BOC Sciences

[5'-O-DMTr-2'-F-dA(Bz)](pCyEt)[2'-F-dU-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-F-dA(Bz)](pCyEt)[2'-F-dU-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-fluoro-deoxyadenosine (2'-F-dA) with a benzoyl (Bz) protecting group, coupled with a 2'-fluoro-deoxyuridine (2'-F-dU). These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.

CAT: BRP-01507

MF: C59H64F2N10O14P2

MF: 1237.16

Purity: ≥97% by HPLC

Appearance: White, off-white to faint yellow powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: FRHVJBZWLACXPX-PXRYCWEGSA-N

IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C59H64F2N10O14P2/c1-37(2)71(38(3)4)86(79-31-13-28-62)84-51-46(83-56(48(51)60)69-30-27-47(72)67-58(69)74)34-81-87(75,80-32-14-29-63)85-52-45(82-57(49(52)61)70-36-66-50-53(64-35-65-54(50)70)68-55(73)39-15-9-7-10-16-39)33-78-59(40-17-11-8-12-18-40,41-19-23-43(76-5)24-20-41)42-21-25-44(77-6)26-22-42/h7-12,15-27,30,35-38,45-46,48-49,51-52,56-57H,13-14,31-34H2,1-6H3,(H,67,72,74)(H,64,65,68,73)/t45-,46-,48-,49-,51-,52-,56-,57-,86?,87?/m1/s1

Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-Fluoro-deoxyadenosine(benzoyl)](pCyEt)[2'-Fluoro-deoxy-U-3'-cyanoethyl-Phosphoramidite]; AfUf; [5'-O-DMTr-2'-F-dA(Bz)](pCyEt)[2'-F-U-3'-CE Phosphoramidite]

[5'-O-DMTr-2'-OMe-A(Bz)](P-thio-pCyEt) [2'-F-dG(iBu)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-A(Bz)](P-thio-pCyEt) [2'-F-dG(iBu)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-adenosine with a benzoyl (Bz) protecting group, coupled with a 2'-fluoro-deoxyguanosine (2'-F-dG) featuring an isobutyryl (iBu) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.

CAT: BRP-01508

MF: C65H74FN13O14P2S

MF: 1374.39

Purity: ≥97% by HPLC

Appearance: White, off-white to faint yellow powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: DQOIBMFRYZHGJO-UMYUGCJYSA-N

IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphorothioyl)oxy)methyl)-4-fluoro-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C65H74FN13O14P2S/c1-39(2)59(80)75-64-74-58-52(61(82)76-64)72-38-78(58)62-50(66)53(92-94(87-32-16-30-67)79(40(3)4)41(5)6)49(90-62)35-89-95(96,88-33-17-31-68)93-54-48(91-63(55(54)85-9)77-37-71-51-56(69-36-70-57(51)77)73-60(81)42-18-12-10-13-19-42)34-86-65(43-20-14-11-15-21-43,44-22-26-46(83-7)27-23-44)45-24-28-47(84-8)29-25-45/h10-15,18-29,36-41,48-50,53-55,62-63H,16-17,32-35H2,1-9H3,(H,69,70,73,81)(H2,74,75,76,80,82)/t48-,49-,50-,53-,54-,55-,62-,63-,94?,95?/m1/s1

Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-A(benzoyl)](P-thio-pCyEt) [2'-Fluoro-deoxy-G(isobutyryl)-3'-cyanoethyl-Phosphoramidite]; AmsGf; [5'-O-DMTr-2'-OMe-dA(Bz)](P thio-pCyEt)[2'-F-G(ibu)-3'-CE Phosphoramidite

[5'-O-DMTr-2'-F-dA(Bz)](P-thio-pCyEt) [2'-OMe-U-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-F-dA(Bz)](P-thio-pCyEt) [2'-OMe-U-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-fluoro-deoxyadenosine (2'-F-dA) with a benzoyl (Bz) protecting group, coupled with a 2'-O-Me-uridine. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.

CAT: BRP-01509

MF: C60H67FN10O14P2S

MF: 1265.26

Purity: ≥97% by HPLC

Appearance: White, off-white to faint yellow powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: JUARPBMSROJZJH-QYUWVQFQSA-N

IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphorothioyl)oxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C60H67FN10O14P2S/c1-38(2)71(39(3)4)86(79-32-14-29-62)84-52-47(83-58(53(52)77-7)69-31-28-48(72)67-59(69)74)35-81-87(88,80-33-15-30-63)85-51-46(82-57(49(51)61)70-37-66-50-54(64-36-65-55(50)70)68-56(73)40-16-10-8-11-17-40)34-78-60(41-18-12-9-13-19-41,42-20-24-44(75-5)25-21-42)43-22-26-45(76-6)27-23-43/h8-13,16-28,31,36-39,46-47,49,51-53,57-58H,14-15,32-35H2,1-7H3,(H,67,72,74)(H,64,65,68,73)/t46-,47-,49-,51-,52-,53-,57-,58-,86?,87?/m1/s1

Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-Fluoro-deoxyadenosine(benzoyl)](P-thio-pCyEt)[2'-O-methyl-U-3'-cyanoethyl-Phosphoramidite]; AfsUm; [5'-O-DMTr-2'-F A(Bz)](P-thio-pCyEt)[2'-OMe-U-3'-CE Phosphoramidite]

[5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-OMe-U](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-OMe-U](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite] is a complex modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of three sequentially linked nucleosides: a 5'-O-DMTr-2'-OMe-guanosine (G) with an isobutyryl (iBu) protecting group, a 2'-OMe-uridine (U), and a 2'-OMe-adenosine (A) with a benzoyl (Bz) protecting group. Each linkage is protected by a cyanoethyl (CE) group, ensuring stability during synthesis. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making them valuable for advanced biochemical research and therapeutic applications.

CAT: BRP-01510

MF: C79H93N16O24P3

MF: 1743.62

Purity: ≥90% by HPLC

Appearance: White, off-white to faint yellow powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: PPJTYZPAIMAICU-AXFAHYDNSA-N

IUPAC Name: (2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((((((2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C79H93N16O24P3/c1-47(2)71(97)90-77-89-70-61(73(99)91-77)86-46-94(70)76-67(107-11)63(56(114-76)41-108-79(51-23-16-13-17-24-51,52-25-29-54(103-7)30-26-52)53-27-31-55(104-8)32-28-53)118-122(102,111-40-20-36-82)113-43-58-64(66(106-10)74(116-58)92-37-33-59(96)87-78(92)100)119-121(101,110-39-19-35-81)112-42-57-62(117-120(109-38-18-34-80)95(48(3)4)49(5)6)65(105-9)75(115-57)93-45-85-60-68(83-44-84-69(60)93)88-72(98)50-21-14-12-15-22-50/h12-17,21-33,37,44-49,56-58,62-67,74-76H,18-20,38-43H2,1-11H3,(H,87,96,100)(H,83,84,88,98)(H2,89,90,91,97,99)/t56-,57-,58-,62-,63-,64-,65-,66-,67-,74-,75-,76-,120?,121?,122?/m1/s1

Synonyms: GmUmAm; [5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-OMe_x005f_x0002_U](pCyEt)[2'-OMe-dA(Bz)-3'-CE-Phosphoramidite]

[5'-O-DMTr-2'-OMe-A(Bz)](pCyEt)[2'-OMe-U](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-A(Bz)](pCyEt)[2'-OMe-U](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite] is a complex modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of three sequentially linked nucleosides: a 5'-O-DMTr-2'-O-methyl-adenosine (2'-OMe-A) with a benzoyl (Bz) protecting group, a 2'-O-methyl-uridine (2'-OMe-U), and another 2'-O-methyl-adenosine (2'-OMe-A) with a benzoyl (Bz) protecting group. Each linkage is protected by a cyanoethyl (CE) group, ensuring stability during synthesis. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making them valuable for advanced biochemical research and therapeutic applications.

CAT: BRP-01511

MF: C82H91N16O23P3

MF: 1761.64

Purity: ≥90% by HPLC

Appearance: White, off-white to faint yellow powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: QLLYUEFHCYOUCU-YNFWSCMJSA-N

IUPAC Name: (2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((((((2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C82H91N16O23P3/c1-51(2)98(52(3)4)122(111-41-19-37-83)119-66-61(117-79(69(66)107-7)96-49-90-64-72(86-47-88-74(64)96)93-76(100)53-22-13-10-14-23-53)45-114-123(103,112-42-20-38-84)121-68-62(118-78(70(68)108-8)95-40-36-63(99)92-81(95)102)46-115-124(104,113-43-21-39-85)120-67-60(116-80(71(67)109-9)97-50-91-65-73(87-48-89-75(65)97)94-77(101)54-24-15-11-16-25-54)44-110-82(55-26-17-12-18-27-55,56-28-32-58(105-5)33-29-56)57-30-34-59(106-6)35-31-57/h10-18,22-36,40,47-52,60-62,66-71,78-80H,19-21,41-46H2,1-9H3,(H,92,99,102)(H,86,88,93,100)(H,87,89,94,101)/t60-,61-,62-,66-,67-,68-,69-,70-,71-,78-,79-,80-,122?,123?,124?/m1/s1

Synonyms: AmUmAm; [5'-O-DMTr-2'-OMe-dA(Bz)](pCyEt)[2'-OMe_x005f_x0002_U](pCyEt)[2'-OMe-dA(Bz)-3'-CE-Phosphoramidite]

[5'-O-DMTr-2'-F-dC(Ac)](pCyEt)[2'-F-dC(Ac)](pCyEt)[2'-F-dA(Bz)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-F-dC(Ac)](pCyEt)[2'-F-dC(Ac)](pCyEt)[2'-F-dA(Bz)-3'-CE-Phosphoramidite] is a complex modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of three sequentially linked nucleosides: a 5'-O-DMTr-2'-fluoro-deoxycytidine (2'-F-dC) with an acetyl (Ac) protecting group, a second 2'-fluoro-deoxycytidine (2'-F-dC) with an acetyl (Ac) protecting group, and a 2'-fluoro-deoxyadenosine (2'-F-dA) with a benzoyl (Bz) protecting group. Each linkage is protected by a cyanoethyl (CE) group, ensuring stability during synthesis. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making them valuable for advanced biochemical research and therapeutic applications.

CAT: BRP-01512

MF: C75H83F3N15O21P3

MF: 1680.49

Purity: ≥90% by HPLC

Appearance: White, off-white to faint yellow powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: AQOHBSZMZWPISB-HLOZHUBLSA-N

IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-5-(4-acetamido-2-oxopyrimidin-1(2H)-yl)-2-((((((2R,3R,4R,5R)-5-(4-acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-4-fluorotetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(6-benzamido-9H-purin-9-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C75H83F3N15O21P3/c1-45(2)93(46(3)4)115(104-37-15-32-79)112-64-56(110-72(60(64)76)92-44-84-63-67(82-43-83-68(63)92)89-69(96)49-18-11-9-12-19-49)41-107-116(99,105-38-16-33-80)114-66-57(111-71(62(66)78)91-36-31-59(86-48(6)95)88-74(91)98)42-108-117(100,106-39-17-34-81)113-65-55(109-70(61(65)77)90-35-30-58(85-47(5)94)87-73(90)97)40-103-75(50-20-13-10-14-21-50,51-22-26-53(101-7)27-23-51)52-24-28-54(102-8)29-25-52/h9-14,18-31,35-36,43-46,55-57,60-62,64-66,70-72H,15-17,37-42H2,1-8H3,(H,82,83,89,96)(H,85,87,94,97)(H,86,88,95,98)/t55-,56-,57-,60-,61-,62-,64-,65-,66-,70-,71-,72-,115?,116?,117?/m1/s1

Synonyms: CfCfAf; [5'-O-DMTr-2'-F-C(Ac)](pCyEt)[2'-F_x005f_x0002_C(Ac)](pCyEt)[2'-F-dA(Bz)-3'-CE-Phosphoramidite]

[5'-O-DMTr-2'-OMe-C(Ac)](P-thio-pCyEt)[2'-OMe-A(Bz)](P-thio-pCyEt)[2'-OMe-G(iBu)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-C(Ac)](P-thio-pCyEt)[2'-OMe-A(Bz)](P-thio-pCyEt)[2'-OMe-G(iBu)-3'-CE-Phosphoramidite] is a complex modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of three sequentially linked nucleosides: a 5'-O-DMTr-2'-O-methyl-cytidine (2'-OMe-C) with an acetyl (Ac) protecting group, a 2'-O-methyl-adenosine (2'-OMe-A) with a benzoyl (Bz) protecting group, and a 2'-O-methyl-guanosine (2'-OMe-G) with an isobutyryl (iBu) protecting group. Each linkage is protected by a phosphorothioate (P-thio) group and a cyanoethyl (CE) group, ensuring stability during synthesis. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making them valuable for advanced biochemical research and therapeutic applications.

CAT: BRP-01513

MF: C81H96N17O22P3S2

MF: 1816.80

Purity: ≥90% by HPLC

Appearance: White, off-white to faint yellow powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: KFIFRWCOOLGJGU-WPIHGYMGSA-N

IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-5-(4-acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphorothioyl)oxy)methyl)-5-(6-benzamido-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphorothioyl)oxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C81H96N17O22P3S2/c1-48(2)73(100)93-79-92-72-63(75(102)94-79)88-47-97(72)77-67(106-10)64(118-121(110-39-19-35-82)98(49(3)4)50(5)6)59(116-77)43-113-122(124,111-40-20-36-83)120-66-60(117-78(69(66)108-12)96-46-87-62-70(85-45-86-71(62)96)91-74(101)52-22-15-13-16-23-52)44-114-123(125,112-41-21-37-84)119-65-58(115-76(68(65)107-11)95-38-34-61(89-51(7)99)90-80(95)103)42-109-81(53-24-17-14-18-25-53,54-26-30-56(104-8)31-27-54)55-28-32-57(105-9)33-29-55/h13-18,22-34,38,45-50,58-60,64-69,76-78H,19-21,39-44H2,1-12H3,(H,85,86,91,101)(H,89,90,99,103)(H2,92,93,94,100,102)/t58-,59-,60-,64-,65-,66-,67-,68-,69-,76-,77-,78-,121?,122?,123?/m1/s1

Synonyms: CmsAmsGm; [5'-O-DMTr-2'-OMe-C(Ac)](P-thio-pCyEt)[2'-OMe dA(Bz)](P-thio-pCyEt)[2'-OMe-G(iBu)-3'-CE_x005f_x0002_Phosphoramidite]

[5'-O-DMTr-2'-OMe-U](pCyEt)[2'-OMe-A(Bz)](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-U](pCyEt)[2'-OMe-A(Bz)](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite] is a complex modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of three sequentially linked nucleosides: a 5'-O-DMTr-2'-O-methyl-uridine (2'-OMe-U), a 2'-O-methyl-adenosine (2'-OMe-A) with a benzoyl (Bz) protecting group, and another 2'-O-methyl-adenosine (2'-OMe-A) with a benzoyl (Bz) protecting group. Each linkage is protected by a cyanoethyl (CE) group, ensuring stability during synthesis. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making them valuable for advanced biochemical research and therapeutic applications.

CAT: BRP-01514

MF: C82H91N16O23P3

MF: 1761.64

Purity: ≥90% by HPLC

Appearance: White, off-white to faint yellow powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: HDBXZWVSPSMPEB-YNFWSCMJSA-N

IUPAC Name: (2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((((((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((((((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C82H91N16O23P3/c1-51(2)98(52(3)4)122(111-41-19-37-83)119-66-61(117-79(69(66)107-7)96-49-90-64-72(86-47-88-74(64)96)93-76(100)53-22-13-10-14-23-53)45-114-123(103,112-42-20-38-84)121-68-62(118-80(71(68)109-9)97-50-91-65-73(87-48-89-75(65)97)94-77(101)54-24-15-11-16-25-54)46-115-124(104,113-43-21-39-85)120-67-60(116-78(70(67)108-8)95-40-36-63(99)92-81(95)102)44-110-82(55-26-17-12-18-27-55,56-28-32-58(105-5)33-29-56)57-30-34-59(106-6)35-31-57/h10-18,22-36,40,47-52,60-62,66-71,78-80H,19-21,41-46H2,1-9H3,(H,92,99,102)(H,86,88,93,100)(H,87,89,94,101)/t60-,61-,62-,66-,67-,68-,69-,70-,71-,78-,79-,80-,122?,123?,124?/m1/s1

Synonyms: UmAmAm; [5'-O-DMTr-2'-OMe-U](pCyEt)[2'-OMe-dA(Bz)](pCyEt)[2'-OMe-dA(Bz)-3'-CE_x005f_x0002_Phosphoramidite]

DMTr-O Diethyleneglycol Phosphoramidite

Description: DMTr-O Diethyleneglycol Phosphoramidite is a phosphoramidite reagent used in solid-phase oligonucleotide synthesis. This phosphoramidite facilitates the efficient and controlled synthesis of oligonucleotides with high purity. The bulky protecting groups on the backbone provide stability during synthesis and can be selectively removed during deprotection steps. This reagent is commonly used in automated oligonucleotide synthesis for various molecular biology and biotechnology applications.

CAT: BRP-01515

CAS: 362013-57-8

MF: C34H45N2O6P

MF: 608.72

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: VTWDQGJYTBUVCR-UHFFFAOYSA-N

CanonicalSMILES: N#CCCOP(OCCOCCOC(C=1C=CC=CC1)(C2=CC=C(OC)C=C2)C3=CC=C(OC)C=C3)N(C(C)C)C(C)C

IUPAC Name: 2-(2-(bis(4-methoxyphenyl)(phenyl)methoxy)ethoxy)ethyl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C34H45N2O6P/c1-27(2)36(28(3)4)43(41-22-10-21-35)42-26-24-39-23-25-40-34(29-11-8-7-9-12-29,30-13-17-32(37-5)18-14-30)31-15-19-33(38-6)20-16-31/h7-9,11-20,27-28H,10,22-26H2,1-6H3

Synonyms: Phosphoramidous acid, bis(1-methylethyl)-, 2-[2-[bis(4-methoxyphenyl)phenylmethoxy]ethoxy]ethyl 2-cyanoethyl ester

5'-Cholesterol PEG5-CE Phosphoramidite

Description: 5'-Cholesterol PEG5-CE Phosphoramidite is a modified phosphoramidite used in oligonucleotide synthesis to introduce a cholesterol moiety and a PEG (polyethylene glycol) spacer at the 5' end of the oligonucleotide. This modification enhances the stability, solubility, and cellular uptake of the oligonucleotide, making it useful for various applications such as antisense therapy, siRNA, and molecular probes.

CAT: BRP-01516

MF: C46H83N2O7P

MF: 807.15

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: ZYJFPTPFCJYMIF-GNUFTJHZSA-N

IUPAC Name: 2-cyanoethyl (14-(((3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-3,6,9,12-tetraoxatetradecyl) diisopropylphosphoramidite

InChI: InChI=1S/C46H83N2O7P/c1-35(2)12-10-13-38(7)42-16-17-43-41-15-14-39-34-40(18-20-45(39,8)44(41)19-21-46(42,43)9)53-32-30-51-28-26-49-24-25-50-27-29-52-31-33-55-56(54-23-11-22-47)48(36(3)4)37(5)6/h14,35-38,40-44H,10-13,15-21,23-34H2,1-9H3/t38-,40+,41+,42-,43+,44+,45+,46-,56?/m1/s1

5'-Biotin Phosphoramidite

Description: 5'-Biotin Phosphoramidite is a modified phosphoramidite used in oligonucleotide synthesis to introduce a biotin molecule at the 5' end of the oligonucleotide. Introducing biotin at the 5' end allows for easy conjugation of the oligonucleotide to streptavidin or avidin, enabling applications like DNA/RNA labeling, pull-down assays, detection of nucleic acid hybridization, and immobilization of oligonucleotides onto solid supports.

CAT: BRP-01517

CAS: 1807503-79-2

MF: C46H64N5O6PS

MF: 846.08

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: RBXYKQBFPLXSJS-UHFFFAOYSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCCCCCNC(=O)CCCCC1C2C(CS1)N(C(=O)N2)C(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OCCC#N

IUPAC Name: 5-[3-[bis(4-methoxyphenyl)-phenylmethyl]-2-oxo-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-6-yl]-N-[6-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxyhexyl]pentanamide

InChI: InChI=1S/C46H64N5O6PS/c1-34(2)51(35(3)4)58(57-32-16-29-47)56-31-15-8-7-14-30-48-43(52)20-13-12-19-42-44-41(33-59-42)50(45(53)49-44)46(36-17-10-9-11-18-36,37-21-25-39(54-5)26-22-37)38-23-27-40(55-6)28-24-38/h9-11,17-18,21-28,34-35,41-42,44H,7-8,12-16,19-20,30-33H2,1-6H3,(H,48,52)(H,49,53)

Synonyms: Phosphoramidous acid, N,N-bis(1-methylethyl)-, 6-[[5-[1-[bis(4-methoxyphenyl)phenylmethyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]hexyl 2-cyanoethyl ester; 6-(5-(1-(Bis(4-methoxyphenyl)(phenyl)methyl)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexyl (2-cyanoethyl) diisopropylphosphoramidite

ICG-NHS

Description: ICG-NHS is synthesized by conjugating NHS to the carboxyl group of ICG, creating an activated ester. This NHS-activated ICG can then react specifically with primary amines on molecules like proteins, peptides, or oligonucleotides to form stable amide bonds. ICG-NHS conjugates are commonly used for labeling biomolecules for imaging, targeting, or drug delivery purposes in biological research and medical diagnostics.

CAT: BRP-01518

CAS: 1622335-40-3

MF: C49H53N3O7S

MF: 828.03

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: KDJUNNVUQBKNAY-UHFFFAOYSA-N

CanonicalSMILES: CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCCC(=O)ON4C(=O)CCC4=O)C=CC=CC=CC=C5C(C6=C(N5CCCCS(=O)(=O)[O-])C=CC7=CC=CC=C76)(C)C)C

IUPAC Name: 4-[2-[7-[3-[6-(2,5-dioxopyrrolidin-1-yl)oxy-6-oxohexyl]-1,1-dimethylbenzo[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethylbenzo[e]indol-3-yl]butane-1-sulfonate

InChI: InChI=1S/C49H53N3O7S/c1-48(2)41(50(39-28-26-35-19-12-14-21-37(35)46(39)48)32-16-8-11-25-45(55)59-52-43(53)30-31-44(52)54)23-9-6-5-7-10-24-42-49(3,4)47-38-22-15-13-20-36(38)27-29-40(47)51(42)33-17-18-34-60(56,57)58/h5-7,9-10,12-15,19-24,26-29H,8,11,16-18,25,30-34H2,1-4H3

Synonyms: 1H-Benz[e]indolium, 2-[7-[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benz[e]indol-2-ylidene]-1,3,5-heptatrien-1-yl]-3-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]-1,1-dimethyl-, inner salt; Indocyanine Green-NHS; 4-(2-(7-(3-(6-((2,5-dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)-1,1-dimethyl-1H-benzo[e]indol-3-ium-2-yl)hepta-2,4,6-trien-1-ylidene)-1,1-dimethyl-1,2-dihydro-3H-benzo[e]indol-3-yl)butane-1-sulfonate; ICG-OSu; ICG NHS ester; ICG-NHS(mono-sulfo-cy7.5 NHS)

12-((2S,4R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxypyrrolidin-1-yl)-12-oxododecanoic acid

Description: 12-((2S,4R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxypyrrolidin-1-yl)-12-oxododecanoic acid is a chemically modified carbohydrate derivative. The peracetylation enhances its stability and lipophilicity, while the GalNAc moiety facilitates specific biological interactions, often used in targeted drug delivery systems. The L96-Acid acts as a linker to connect GalNAc to other functional groups or molecules, and the TEA salt ensures solubility and stability in solution. This compound is useful in pharmaceutical and biochemical applications, particularly in the development of targeted therapeutics and diagnostic agents.

CAT: BRP-01519

CAS: 1159408-70-4

MF: C38H49NO7

MF: 631.81

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.154±0.06 g/cm3

Boiling Point: 779.4±60.0 °C at 760 mmHg

InChIKey: CEYLTMDXADTBEL-JHOUSYSJSA-N

CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4CC(CN4C(=O)CCCCCCCCCCC(=O)O)O

IUPAC Name: 12-[(2S,4R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxypyrrolidin-1-yl]-12-oxododecanoic acid

InChI: InChI=1S/C38H49NO7/c1-44-34-22-18-30(19-23-34)38(29-14-10-9-11-15-29,31-20-24-35(45-2)25-21-31)46-28-32-26-33(40)27-39(32)36(41)16-12-7-5-3-4-6-8-13-17-37(42)43/h9-11,14-15,18-25,32-33,40H,3-8,12-13,16-17,26-28H2,1-2H3,(H,42,43)/t32-,33+/m0/s1

Synonyms: 1-Pyrrolidinedodecanoic acid, 2-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-4-hydroxy-λ-oxo-, (2S,4R)-; (2S,4R)-2-[[Bis(4-methoxyphenyl)phenylmethoxy]methyl]-4-hydroxy-λ-oxo-1-pyrrolidinedodecanoic acid; Peracetylated GalNAc-L96-Acid-2

5'-DMT-PseudoUridine-CE-Phosphoramidite

Description: 5'-DMT-PseudoUridine-CE-Phosphoramidite is a phosphoramidite used in the chemical synthesis of oligonucleotides. This compound features a 5'-dimethoxytrityl (DMT) protecting group and a cyanoethyl (CE) phosphoramidite moiety, making it compatible with automated DNA/RNA synthesis protocols. Incorporating pseudouridine into synthetic RNA strands using this phosphoramidite is particularly valuable for research into RNA modifications, as pseudouridine can influence RNA stability, folding, and function. This tool aids in the development of RNA-based therapeutics and the study of RNA biology, enabling detailed exploration of pseudouridine's role in various cellular processes.

CAT: BRP-01520

CAS: 1244969-51-4

MF: C39H47N4O9P

MF: 746.79

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: OMNBXPQZUMXZPM-LWYRIDHVSA-N

CanonicalSMILES: N#CCCOP(OC1C(O)C(OC1COC(C=2C=CC=CC2)(C3=CC=C(OC)C=C3)C4=CC=C(OC)C=C4)C5=CNC(=O)NC5=O)N(C(C)C)C(C)C

IUPAC Name: (2R,3S,4S,5S)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4-hydroxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C39H47N4O9P/c1-25(2)43(26(3)4)53(50-22-10-21-40)52-36-33(51-35(34(36)44)32-23-41-38(46)42-37(32)45)24-49-39(27-11-8-7-9-12-27,28-13-17-30(47-5)18-14-28)29-15-19-31(48-6)20-16-29/h7-9,11-20,23,25-26,33-36,44H,10,22,24H2,1-6H3,(H2,41,42,45,46)/t33-,34+,35+,36-,53?/m1/s1

Synonyms: 2,4(1H,3H)-Pyrimidinedione, 5-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-β-D-ribofuranosyl]-; 5-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-β-D-ribofuranosyl]-2,4(1H,3H)-pyrimidinedione; 5'-DMT-PseudoUridine 3'-CE-Phosphoramidite

5'-ODMT cEt G Phosphoramidite (Amidite)

Description: 5'-ODMT cEt G Phosphoramidite is a specialized chemical reagent used in the synthesis of oligonucleotides. This compound features a guanosine (G) base modified with a 5'-O-(4,4'-dimethoxytrityl) (DMT) protecting group and a constrained ethyl (cEt) modification. The constrained ethyl (cEt) modification is designed to enhance the stability and binding affinity of the oligonucleotide, making it more resistant to nuclease degradation and improving its hybridization properties. This modification is particularly useful in the development of therapeutic oligonucleotides, such as antisense oligonucleotides, small interfering RNAs (siRNAs), and other nucleic acid-based drugs.

CAT: BRP-01526

CAS: 945628-66-0

MF: C46H56N7O9P

MF: 881.95

Purity: ≥98% by HPLC

Appearance: White to off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, stored under nitrogen, away from moisture

InChIKey: VMDSRWMHPUGGSZ-KHGLYSIJSA-N

Solubility: Soluble in DMSO

CanonicalSMILES: CC1C2(C(C(O1)C(O2)N3C=NC4=C3N=C(NC4=O)NC(=O)C(C)C)OP(N(C(C)C)C(C)C)OCCC#N)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC

IUPAC Name: N-[9-[(1S,3R,4R,6S,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide

InChI: InChI=1S/C46H56N7O9P/c1-28(2)41(54)50-44-49-40-37(42(55)51-44)48-27-52(40)43-38-39(62-63(59-25-13-24-47)53(29(3)4)30(5)6)45(61-43,31(7)60-38)26-58-46(32-14-11-10-12-15-32,33-16-20-35(56-8)21-17-33)34-18-22-36(57-9)23-19-34/h10-12,14-23,27-31,38-39,43H,13,25-26H2,1-9H3,(H2,49,50,51,54,55)/t31-,38+,39-,43+,45-,63?/m0/s1

Synonyms: 5'-ODMT cEt G Phosphoramidite; S-cEt-G phosphoramidite; (1S,3R,4R,6S,7S)-1-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-7-yl (2-cyanoethyl) diisopropylphosphoramidite; N-[9-[2,5-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-6-deoxy-α-L-mannofuranosyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-2-methylpropanamide; S-cEt-G(iBu) phosphoramidite; CET-rG(ibu) Phosphoramidite; S-cEt-G(iBu)-CE-Phosphoramidite

5'-ODMT cEt m5U Phosphoramidite (Amidite)

Description: 5'-ODMT cEt m5U Phosphoramidite (Amidite) is a specialized chemical reagent used in the synthesis of oligonucleotides. This compound features a modified uridine (m5U) base, where the uridine is methylated at the 5-position, and includes a constrained ethyl (cEt) modification. Additionally, the 5' hydroxyl group is protected by a 4,4'-dimethoxytrityl (DMT) group. The constrained ethyl (cEt) modification enhances the stability and binding affinity of the oligonucleotide, making it more resistant to nuclease degradation and improving its hybridization properties. The methylation at the 5-position of uridine (m5U) is known to influence the binding affinity and specificity of the oligonucleotide to its target. This phosphoramidite is particularly useful in the development of therapeutic oligonucleotides, such as antisense oligonucleotides, small interfering RNAs (siRNAs), and other nucleic acid-based drugs, where enhanced stability and binding affinity are crucial for efficacy.

CAT: BRP-01527

CAS: 1197033-22-9

MF: C42H51N4O9P

MF: 786.86

Purity: ≥98% by HPLC

Appearance: White to off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, stored under nitrogen, away from moisture

InChIKey: SEFBXGXPINACNI-IMMRMUFKSA-N

Solubility: Soluble in DMSO

CanonicalSMILES: CC1C2(C(C(O1)C(O2)N3C=C(C(=O)NC3=O)C)OP(N(C(C)C)C(C)C)OCCC#N)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC

IUPAC Name: 3-[[(1S,3R,4R,6S,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-6-methyl-3-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-7-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C42H51N4O9P/c1-27(2)46(28(3)4)56(52-24-12-23-43)55-37-36-39(45-25-29(5)38(47)44-40(45)48)54-41(37,30(6)53-36)26-51-42(31-13-10-9-11-14-31,32-15-19-34(49-7)20-16-32)33-17-21-35(50-8)22-18-33/h9-11,13-22,25,27-28,30,36-37,39H,12,24,26H2,1-8H3,(H,44,47,48)/t30-,36+,37-,39+,41-,56?/m0/s1

Synonyms: 1-[2,5-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-6-deoxy-α-L-mannofuranosyl]-5-methyl-2,4(1H,3H)-pyrimidinedione; 5'-ODMT cEt m5U Phosphoramidite; S-cEt-m5U phosphoramidite; CET-m5U Phosphoramidite; S-cEt-m5U-CE-Phosphoramidite; S-cEt-T phosphoramidite; CET-5-Me-U Phosphoramidite; S-cEt-T-CE-Phosphoramidite

5'-ODMT cEt N-Bz A Phosphoramidite (Amidite)

Description: 5'-ODMT cEt N-Bz A Phosphoramidite (Amidite) is a specialized reagent used in the chemical synthesis of oligonucleotides. This compound features an adenine (A) base with an N6-benzoyl (N-Bz) protection and a constrained ethyl (cEt) modification, along with a 5'-O-(4,4'-dimethoxytrityl) (DMT) protecting group. The constrained ethyl (cEt) modification enhances the stability and binding affinity of the oligonucleotide. This modification increases resistance to nuclease degradation and improves hybridization properties, making the resulting oligonucleotide more effective for various applications, including therapeutic uses. 5'-ODMT cEt N-Bz A Phosphoramidite (Amidite) is an important reagent for the synthesis of modified oligonucleotides, offering enhanced stability, binding affinity, and efficacy. It is particularly useful in the development of therapeutic oligonucleotides and other advanced nucleic acid-based research applications.

CAT: BRP-01528

CAS: 1197033-19-4

MF: C49H54N7O8P

MF: 899.97

Purity: ≥98% by HPLC

Appearance: White to off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, stored under nitrogen, away from moisture

InChIKey: XHEVZGBLRSIPCO-DZGFXGBPSA-N

Solubility: Soluble in DMSO

CanonicalSMILES: CC1C2(C(C(O1)C(O2)N3C=NC4=C(N=CN=C43)NC(=O)C5=CC=CC=C5)OP(N(C(C)C)C(C)C)OCCC#N)COC(C6=CC=CC=C6)(C7=CC=C(C=C7)OC)C8=CC=C(C=C8)OC

InChI: InChI=1S/C49H54N7O8P/c1-32(2)56(33(3)4)65(61-28-14-27-50)64-43-42-47(55-31-53-41-44(51-30-52-45(41)55)54-46(57)35-15-10-8-11-16-35)63-48(43,34(5)62-42)29-60-49(36-17-12-9-13-18-36,37-19-23-39(58-6)24-20-37)38-21-25-40(59-7)26-22-38/h8-13,15-26,30-34,42-43,47H,14,28-29H2,1-7H3,(H,51,52,54,57)/t34-,42+,43-,47+,48-,65?/m0/s1

Synonyms: S-cEt-A phosphoramidite; 5'-ODMT cEt N-Bz A Phosphoramidite; 5'-ODMT cEt A(Bz) Phosphoramidite; N6-Bz-2'-O-4'-A-Locked-Ar-CET-Phosphoramidite; CET-A(Bz) Phosphoramidite; 5'-ODMT cEt N-Bz A Phosphoramidite Amidite; S-cEt-A(Bz)-CE-Phosphoramidite; N-[9-[2,5-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-6-deoxy-α-L-mannofuranosyl]-9H-purin-6-yl]benzamide

5'-ODMT cEt U Phosphoramidite (Amidite)

Description: 5'-ODMT cEt U Phosphoramidite (Amidite) is a specialized chemical reagent used in the synthesis of oligonucleotides. This compound features a uridine (U) base modified with a 5'-O-(4,4'-dimethoxytrityl) (DMT) protecting group and a constrained ethyl (cEt) modification. The constrained ethyl (cEt) modification is designed to enhance the stability and binding affinity of the oligonucleotide. This modification makes the oligonucleotide more resistant to nuclease degradation and improves its hybridization properties. The use of such modifications is particularly important in the development of therapeutic oligonucleotides, such as antisense oligonucleotides, small interfering RNAs (siRNAs), and other nucleic acid-based drugs, where stability and binding affinity are crucial for efficacy.

CAT: BRP-01529

CAS: 945628-51-3

MF: C41H49N4O9P

MF: 772.82

Purity: ≥98% by HPLC

Appearance: White to off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, stored under nitrogen, away from moisture

InChIKey: MCMVDDGYNXOEJR-ZDHUYCFVSA-N

Solubility: Soluble in DMSO

CanonicalSMILES: CC1C2(C(C(O1)C(O2)N3C=CC(=O)NC3=O)OP(N(C(C)C)C(C)C)OCCC#N)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC

IUPAC Name: 3-[[(1S,3R,4R,6S,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-(2,4-dioxopyrimidin-1-yl)-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-7-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C41H49N4O9P/c1-27(2)45(28(3)4)55(51-25-11-23-42)54-37-36-38(44-24-22-35(46)43-39(44)47)53-40(37,29(5)52-36)26-50-41(30-12-9-8-10-13-30,31-14-18-33(48-6)19-15-31)32-16-20-34(49-7)21-17-32/h8-10,12-22,24,27-29,36-38H,11,25-26H2,1-7H3,(H,43,46,47)/t29-,36+,37-,38+,40-,55?/m0/s1

Synonyms: 1-[2,5-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-6-deoxy-α-L-mannofuranosyl]-2,4(1H,3H)-pyrimidinedione; 5'-ODMT cEt U Phosphoramidite; S-cEt-U phosphoramidite; CET-U Phosphoramidite; S-cEt-U-CE-Phosphoramidite; cEt U Amidite

5'-ODMT cEt N-Bz C Phosphoramidite (Amidite)

Description: 5'-ODMT cEt N-Bz C Phosphoramidite (Amidite) is a specialized chemical reagent used in the synthesis of modified oligonucleotides. This compound features a cytosine (C) base with an N4-benzoyl (N-Bz) protecting group and a constrained ethyl (cEt) modification, along with a 5'-O-(4,4'-dimethoxytrityl) (DMT) protective group. The constrained ethyl (cEt) modification enhances the stability and binding affinity of the resulting oligonucleotide. This modification increases resistance to nuclease degradation and improves hybridization properties, which is crucial for various research and therapeutic applications. 5'-ODMT cEt N-Bz C Phosphoramidite (Amidite) is an essential reagent for synthesizing modified oligonucleotides, providing enhanced stability, binding affinity, and resistance to degradation, particularly useful in developing advanced nucleic acid-based therapeutics and research tools.

CAT: BRP-01530

CAS: 945628-57-9

MF: C48H54N5O9P

MF: 875.94

Purity: ≥98% by HPLC

Appearance: White to off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C, stored under nitrogen, away from moisture

InChIKey: QLEUKMYYYZVVED-INXIQYKVSA-N

Solubility: Soluble in DMSO

CanonicalSMILES: CC1C2(C(C(O1)C(O2)N3C=CC(=NC3=O)NC(=O)C4=CC=CC=C4)OP(N(C(C)C)C(C)C)OCCC#N)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC

IUPAC Name: N-[1-[(1S,3R,4R,6S,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-2-oxopyrimidin-4-yl]benzamide

InChI: InChI=1S/C48H54N5O9P/c1-32(2)53(33(3)4)63(59-30-14-28-49)62-43-42-45(52-29-27-41(51-46(52)55)50-44(54)35-15-10-8-11-16-35)61-47(43,34(5)60-42)31-58-48(36-17-12-9-13-18-36,37-19-23-39(56-6)24-20-37)38-21-25-40(57-7)26-22-38/h8-13,15-27,29,32-34,42-43,45H,14,30-31H2,1-7H3,(H,50,51,54,55)/t34-,42+,43-,45+,47-,63?/m0/s1

Synonyms: S-cEt-C phosphoramidite; 5'-ODMT cEt N-Bz C Phosphoramidite; 5'-ODMT cEt C(Bz) Phosphoramidite; N4-Bz-2'-O-4'-A-Locked-Cr-CET-Phosphoramidite; CET-C(Bz) Phosphoramidite; 5'-ODMT cEt N-Bz C Phosphoramidite Amidite; S-cEt-C(Bz)-CE-Phosphoramidite; N-[1-[2,5-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-6-deoxy-α-L-mannofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]benzamide

DMT-2'-F-dG(DMF)-CE-Phosphoramidite

Description: DMT-2'-F-dG(DMF)-CE-Phosphoramidite is a chemically modified phosphoramidite utilized in the solid-phase synthesis of oligonucleotides. The modifications, including the fluorine at the 2' position and the protecting groups, enhance the stability and specificity of the synthesized oligonucleotides. These modifications can be critical for applications in genetic research, diagnostics, and the development of antisense oligonucleotides, siRNA, and other nucleic acid-based therapeutics. The fluorine substitution particularly contributes to increased resistance against enzymatic degradation, making the oligonucleotides more durable and effective in biological systems.

CAT: BRP-01539

MF: C43H52FN8O7P

MF: 842.91

Purity: ≥98%

Appearance: White solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: BUKKJOTXODUNQK-PKTARBJSSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1F)N2C=NC3=C2N=C(NC3=O)N=CN(C)C)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC

IUPAC Name: N'-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide

InChI: InChI=1S/C43H52FN8O7P/c1-28(2)52(29(3)4)60(57-24-12-23-45)59-38-35(58-41(36(38)44)51-27-46-37-39(51)48-42(49-40(37)53)47-26-50(5)6)25-56-43(30-13-10-9-11-14-30,31-15-19-33(54-7)20-16-31)32-17-21-34(55-8)22-18-32/h9-11,13-22,26-29,35-36,38,41H,12,24-25H2,1-8H3,(H,48,49,53)/t35-,36-,38-,41-,60?/m1/s1

Synonyms: 2'-F G(dmf) amidite; 2'-Fluoro-2'-deoxy Guanosine (N,N-DMF) CED Phosphoramidite; (2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-(((dimethylamino)methylene)amino)-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

Related CAS: 1391913-24-8 (N'-[9-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-deoxy-2-fluoro-β-D-arabinofuranosyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide)